Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts

Summary

Previous studies have suggested that breast cancer stem cells (BCSCs) mediate metastasis, are resistant to radiation and chemotherapy, and contribute to relapse. Although several BCSC markers have been described, it is unclear whether these markers identify the same or independent BCSCs. Here, we show that BCSCs exist in distinct mesenchymal-like (epithelial-mesenchymal transition [EMT]) and epithelial-like (mesenchymal-epithelial transition [MET]) states. Mesenchymal-like BCSCs characterized as CD24 ⁻CD44 ⁺ are primarily quiescent and localized at the tumor invasive front, whereas epithelial-like BCSCs express aldehyde dehydrogenase (ALDH), are proliferative, and are located more centrally. The gene-expression profiles of mesenchymal-like and epithelial-like BCSCs are remarkably similar across different molecular subtypes of breast cancer, and resemble those of distinct basal and luminal stem cells found in the normal breast. We propose that the plasticity of BCSCs that allows them to transition between EMT- and MET-like states endows these cells with the capacity for tissue invasion, dissemination, and growth at metastatic sites.

Highlights

• •

  BCSCs exist in EMT and MET states with distinct marker and gene-expression profiles

• •

  CSCs from different subtypes of breast cancer express common EMT/MET genes

• •

  EMT and MET BCSC profiles resemble normal mammary basal and luminal stem cells

• •

  BCSCs display plasticity that enables them to transition between EMT and MET states

Abstract

Breast cancer stem cells (BCSCs) are thought to mediate metastasis and resistance to radiation and chemotherapy. Here, Liu et al. show that BCSCs exist in distinct mesenchymal-like (CD24 ⁻CD44 ⁺) and epithelial-like (ALDH ⁺) states with different proliferative and invasive capacities, suggesting it may be clinically important to target alternative CSC states.